Markets rose on Wednesday despite a weaker-than-expected reading on the services sector. Is the economy in the middle of a recovery and if so, how can investors play it? Bill Spiropoulos, CEO of CoreStates Capital Advisors and John Merrill, founder and CIO of Tanglewood Wealth Management shared their insights.    Read More

How can you invest along the same principles as Warren Buffett? James Altucher, managing director of Formula Capital, shared his insights.    Read More

Dividends can be a way for investors to effectively safeguard returns during volatile times. Joseph Keating, CIO of Private Asset Management at RBC Bank shared some of his best dividend picks for investors.    Read More

While the Burlington Northern deal is getting a lot of attention, it has not brought pre-open trading in the S&P futures into positive territory yet. Risk aversion has become a more prominent theme since last Wednesday, when the S&P 500 dropped below its 50-day moving average for the first time since July.    Read More

Over the past few days there's been a remarkable confluence of newsflow, most of it positive, out of biopharma. First the bad news.    Read More

We asked the traders for their favorite stocks to 'buy and hold' for the long-term. After all, good things come to those who wait!   Read More

Markets rose on Thursday after data showed the economy grew more than expected last quarter and jobless claims fell. How should investors be positioning their portfolios now? Dan Genter, president, CEO and CIO of RNC Genter Capital Management, and Dean Barber, founder and president of Barber Financial Group, shared their market insights.    Read More

With Microsoft's earnings report this morning, two thirds of the Dow 30 have now reported.  Here is a summary of how things stand in terms of EPS and revenues.   Read More

One of the things we learned in Pfizer's earnings press release and on the conference call today is that since the start of 2008 the company has eliminated 11,200 positions. And now that the world's biggest pharmaceutical firm has gotten even bigger by swallowing Wyeth, it's going to let go even more people to help wring out about $4 billion in annual expenses by 2012.   Read More

Stocks opened mixed after several earnings reports beat expectations but economic numbers missed their targets. Dan Genter of RNC Genter Capital Management and Alan Gayle of RidgeWorth Capital Management shared their market outlooks.   Read More